UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 333

Sortiert nach

A computer algorithm for determining the tensile strength of float glass

Engineering structures, 2012-12, Vol.45, p.68-77

2012

Volltextzugriff (PDF)

Sleep Duration as a Risk Factor for Diabetes Incidence in a Large US Sample

Sleep (New York, N.Y.), 2007-12, Vol.30 (12), p.1667-1673

2007

Volltextzugriff (PDF)

Earlier Parental Set Bedtimes as a Protective Factor Against Depression and Suicidal Ideation

Sleep (New York, N.Y.), 2010, Vol.33 (1), p.97-106

2010

Volltextzugriff (PDF)

Insomnia and Sleep Duration as Mediators of the Relationship Between Depression and Hypertension Incidence

American journal of hypertension, 2010-01, Vol.23 (1), p.62-69

2010

Volltextzugriff (PDF)

Short Sleep Duration as a Risk Factor for Hypertension: Analyses of the First National Health and Nutrition Examination Survey

Hypertension (Dallas, Tex. 1979), 2006-05, Vol.47 (5), p.833-839

2006

Volltextzugriff (PDF)

Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia

Current medical research and opinion, 2004-12, Vol.20 (12), p.1979-1991

2004

Volltextzugriff (PDF)

Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial

American journal of respiratory and critical care medicine, 2019-06, Vol.199 (11), p.1421-1431

2019

Volltextzugriff (PDF)

Comparison of actigraphy and polysomnography to assess effects of zolpidem in a clinical research unit

Sleep medicine, 2012-04, Vol.13 (4), p.419-424

2012

Volltextzugriff (PDF)

Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study

Journal of sleep research, 2020-08, Vol.29 (4), p.e13021-n/a

2020

Volltextzugriff (PDF)

Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment

Chest, 2021-07, Vol.160 (1), p.307-318

2021

Volltextzugriff (PDF)

Earlier parental set bedtimes as a protective factor against depression and suicidal ideation

Sleep (New York, N.Y.), 2010-01, Vol.33 (1), p.97-106

2010

Volltextzugriff (PDF)

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study

Sleep (New York, N.Y.), 2008-01, Vol.31 (1), p.79-90

2008

Volltextzugriff (PDF)

An evaluation of the behaviour-change techniques used on Canadian cancer centre Web sites to support physical activity behaviour for breast cancer survivors

Current oncology (Toronto), 2017-12, Vol.24 (6), p.e477-485

2017

Volltextzugriff (PDF)

Quality of life in people with insomnia

Sleep (New York, N.Y.), 1999-05, Vol.22 Suppl 2, p.S379-S385

1999

Volltextzugriff (PDF)

Alterations in sleep architecture in response to experimental sleep curtailment are associated with signs of positive energy balance

American journal of physiology. Regulatory, integrative and comparative physiology, 2012-11, Vol.303 (9), p.R883-R889

2012

Volltextzugriff (PDF)

Work-shift period and weight change

Nutrition (Burbank, Los Angeles County, Calif.), 2000, Vol.16 (1), p.27-29

2000

Volltextzugriff (PDF)

Anaemia in elderly Maltese nursing home residents

European geriatric medicine, 2012-09, Vol.3, p.S82-S82

2012

Volltextzugriff (PDF)

The effect of vestibular stimulation in a four-hour sleep phase advance model of transient insomnia

Journal of clinical sleep medicine, 2010-08, Vol.6 (4), p.315-321

2010

Volltextzugriff (PDF)

A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults

Human psychopharmacology, 2022-01, Vol.37 (1), p.e2806-n/a

2022

Volltextzugriff (PDF)

Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Clinical drug investigation, 2021-05, Vol.41 (5), p.449-457

2021

Volltextzugriff (PDF)

P.050 Effect of lemborexant on sleep architecture in adult and elderly subjects with mild to severe obstructive sleep apnea

Canadian journal of neurological sciences, 2023-06, Vol.50 (s2), p.S71-S72

2023

Volltextzugriff (PDF)

Sleep Duration Associated with Mortality in Elderly, but not Middle-Aged, Adults in a Large US Sample

Sleep (New York, N.Y.), 2008-08, Vol.31 (8), p.1087-1096

2008

Volltextzugriff (PDF)

P.047 Effect of lemborexant on sleep architecture in subjects with comorbid insomnia and mild obstructive sleep apnea from a phase 3 trial

Canadian journal of neurological sciences, 2023-06, Vol.50 (s2), p.S71-S71

2023

Volltextzugriff (PDF)

Reliability and Validity of the Brief Insomnia Questionnaire in the America Insomnia Survey

Sleep (New York, N.Y.), 2010-11, Vol.33 (11), p.1539-1549

2010

Volltextzugriff (PDF)

The prevalence, morbidities, and treatments of insomnia

CNS & neurological disorders drug targets, 2007-02, Vol.6 (1), p.3

Zammit, Gary K

2007

Volltextzugriff (PDF)

1 – 25 von 333

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(299)
Mit Volltextzugriff
(304)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(203)
Life Sciences & Biomedicine
(163)
Humans
(130)
Female
(88)
Male
(82)
Adult
(61)
Middle Aged
(54)
Biological And Medical Sciences
(51)
Medical Sciences
(42)
Neurosciences & Neurology
(40)
Aged
(35)
Physical Sciences
(34)
Animals
(33)
Neurosciences
(28)
Clinical Neurology
(24)
Psychology. Psychoanalysis. Psychiatry
(24)
Psychiatry
(23)
Aged, 80 And Over
(21)
Surgery
(21)
Adolescent
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

A computer algorithm for determining the tensile strength of float glass

Sleep Duration as a Risk Factor for Diabetes Incidence in a Large US Sample

Earlier Parental Set Bedtimes as a Protective Factor Against Depression and Suicidal Ideation

Insomnia and Sleep Duration as Mediators of the Relationship Between Depression and Hypertension Incidence

Short Sleep Duration as a Risk Factor for Hypertension: Analyses of the First National Health and Nutrition Examination Survey

Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia

Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial

Comparison of actigraphy and polysomnography to assess effects of zolpidem in a clinical research unit

Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study

Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment

Earlier parental set bedtimes as a protective factor against depression and suicidal ideation

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study

An evaluation of the behaviour-change techniques used on Canadian cancer centre Web sites to support physical activity behaviour for breast cancer survivors

Quality of life in people with insomnia

Alterations in sleep architecture in response to experimental sleep curtailment are associated with signs of positive energy balance

Work-shift period and weight change

Anaemia in elderly Maltese nursing home residents

The effect of vestibular stimulation in a four-hour sleep phase advance model of transient insomnia

A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults

Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study

P.050 Effect of lemborexant on sleep architecture in adult and elderly subjects with mild to severe obstructive sleep apnea

Sleep Duration Associated with Mortality in Elderly, but not Middle-Aged, Adults in a Large US Sample

P.047 Effect of lemborexant on sleep architecture in subjects with comorbid insomnia and mild obstructive sleep apnea from a phase 3 trial

Reliability and Validity of the Brief Insomnia Questionnaire in the America Insomnia Survey

The prevalence, morbidities, and treatments of insomnia

Suchergebnisse filtern